Naproplat Injection
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Naproplat Injection contains carboplatin, a platinum-based cytotoxic (chemotherapy) medicine. Its labelling describes it for the treatment of ovarian cancer and small-cell lung cancer, given alone or in combination with other anticancer medicines. It is described as damaging the DNA and RNA of cancer cells to stop their growth and multiplication, and is administered into a vein only under the supervision of a doctor.
Product Information
The following description reflects information associated with carboplatin and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the treatment of ovarian cancer
- Described for the treatment of small-cell lung cancer
- Described as used alone or in combination with other anticancer medicines, as determined by the oncologist
- Described as damaging the DNA and RNA of cancer cells to stop their growth and multiplication
Described Dosage & Administration
- Administered only by a doctor into a vein — not self-administered
- The dose and duration are set by the oncology team and may change according to treatment progress
- Benefits are described as taking weeks or months to become visible
Described Side Effects
Commonly described side effects include:
- Nausea and vomiting
- Anaemia (low number of red blood cells)
- Low blood platelet count
- Tiredness (fatigue)
- Raised liver enzymes
- Diarrhoea
Regular blood tests are described as carried out for monitoring. Any severe, persistent, or unexpected reaction requires prompt medical attention.
Precautions
- Regular blood tests should be cooperated with during treatment
- A full medical history should be shared with the doctor to avoid an inappropriate medicine combination
- Effective contraception should be used to avoid pregnancy; it is described as not recommended during pregnancy or breastfeeding
- Any persistent or severe side effect should be reviewed by a clinician
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains carboplatin, a platinum-based chemotherapy medicine used to treat ovarian cancer and small-cell lung cancer, alone or with other anticancer medicines. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling states it is administered by a doctor into a vein, at the dose and schedule set by the oncology team. It is not self-administered, and benefits may take weeks or months to appear.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.